concept

CHOLINERGIC

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CHOLINERGIC: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

292Connections

17Hypotheses

0Analyses

50Outgoing

50Incoming

15Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	CHOLINERGIC
Key Genes/Proteins	ACHE, AD, AKT, APOE, APP
Related Diseases	ALZHEIMER, ALZHEIMER'S, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS
Related Pathways	APOPTOSIS

Pathway Diagram

graph TD
    CHOLINERGIC["CHOLINERGIC"]
    CHOLINERGIC -->|"activates"| OXIDATIVE_STRESS["OXIDATIVE STRESS"]
    CHOLINERGIC -.biomarker for.-> TUMOR["TUMOR"]
    CHOLINERGIC -->|"expressed in"| NEURON["NEURON"]
    CHOLINERGIC -->|"expressed in"| NEURONS["NEURONS"]
    CHOLINERGIC -->|"contributes to"| INFLAMMATION["INFLAMMATION"]
    CHOLINERGIC -->|"contributes to"| NEURODEGENERATION["NEURODEGENERATION"]
    CHOLINERGIC -->|"contributes to"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    AMYLOID["AMYLOID"] -->|"activates"| CHOLINERGIC
    ALZHEIMER["ALZHEIMER"] -.protects against.-> CHOLINERGIC
    ALZHEIMER_S["ALZHEIMER'S"] -.protects against.-> CHOLINERGIC
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -.protects against.-> CHOLINERGIC
    AGING["AGING"] -->|"contributes to"| CHOLINERGIC

Outgoing (194)

Target	Relation	Type	Str
NEURONS	markers	cell_type	0.70
TNF	activates	gene	0.70
NRF2	activates	gene	0.70
CREB	inhibits	gene	0.70
HTR2A	regulates	gene	0.70
TAU	markers	gene	0.70
GABAERGIC	regulates	cell_type	0.70
GSK3B	markers	gene	0.70
MACROPHAGE	regulates	cell_type	0.70
TAU	causes	gene	0.70
CHRNA7	regulates	gene	0.70
SLC6A4	regulates	gene	0.70
STING	inhibits	gene	0.70
MICROGLIA	associated_with	cell_type	0.70
DRD2	activates	gene	0.70
GFAP	activates	gene	0.70
CHRNA7	causes	gene	0.70
CHRNA7	transports	gene	0.70
NLRP3	activates	gene	0.70
TAU	activates	gene	0.70
NEURONS	activates	cell_type	0.70
CHRNA7	associated_with	gene	0.70
GRIA1	activates	gene	0.70
NEURONS	protects_against	cell_type	0.70
LAMP1	interacts_with	gene	0.70
TAU	phosphorylates	gene	0.65
TAU	protects_against	gene	0.65
NEURONS	causes	cell_type	0.65
GLIOBLASTOMA	causes	disease	0.65
DONEPEZIL	promotes	drug	0.65
MEMANTINE	promotes	drug	0.65
TAU	regulates	gene	0.65
NEURON	causes	cell_type	0.65
SCHIZOPHRENIA	contributes_to	disease	0.60
T CELLS	activates	cell_type	0.60
TUMOR	biomarker_for	disease	0.60
T CELL	activates	cell_type	0.60
NEURONS	expressed_in	cell_type	0.60
NEURON	regulates	cell_type	0.60
NEURONS	regulates	cell_type	0.60
SREBF2	targets	gene	0.60
STING	causes	gene	0.60
CREB	activates	gene	0.60
LRRK2	inhibits	gene	0.60
MAO	inhibits	gene	0.60
PERICYTE	expresses	cell_type	0.60
PERICYTES	expresses	cell_type	0.60
NEUROINFLAMMATION	causes	pathway	0.60
NEURON	interacts_with	cell_type	0.60
NEURON	activates	cell_type	0.60

Incoming (98)

Source	Relation	Type	Str
CHAT	activates	gene	0.70
ATG5	inhibits	gene	0.70
ATG7	inhibits	gene	0.70
BDNF	activates	gene	0.70
APP	inhibits	gene	0.70
BDNF	inhibits	gene	0.70
ALZHEIMER'S DISEASE	protects_against	disease	0.60
ALZHEIMER	associated_with	disease	0.60
CHAT	causes	gene	0.60
ALZHEIMER	protects_against	disease	0.60
ALZHEIMER'S	protects_against	disease	0.60
AΒ	markers	gene	0.60
AD	degrades	gene	0.60
ALZHEIMER'S DISEASE	degrades	disease	0.60
APP	degrades	gene	0.60
ALZHEIMER'S	associated_with	disease	0.60
ALZHEIMER'S DISEASE	associated_with	disease	0.60
APOE	causes	gene	0.60
APOE	associated_with	gene	0.60
CHAT	expresses	gene	0.60
ACHE	regulates	gene	0.60
CAT	regulates	gene	0.60
CHAT	regulates	gene	0.60
AKT	activates	gene	0.60
AD	inhibits	gene	0.60
AΒ	regulates	gene	0.60
AΒ	co_discussed	gene	0.60
AΒ	causes	gene	0.60
BAX	enhances	gene	0.60
ASTROCYTES	activates	cell_type	0.60
ALZHEIMER'S DISEASE	interacts_with	disease	0.60
AD	protects_against	gene	0.60
APOPTOSIS	markers	pathway	0.60
AΒ	inhibits	gene	0.60
ALZHEIMER'S DISEASE	targets	disease	0.60
APOPTOSIS	activates	pathway	0.60
ASTROCYTES	inhibits	cell_type	0.60
AD	enhances	gene	0.60
APOPTOSIS	inhibits	pathway	0.60
AΒ	activates	gene	0.60
APP	expresses	gene	0.60
ACHE	associated_with	gene	0.60
APP	associated_with	gene	0.60
ACHE	activates	gene	0.60
APP	causes	gene	0.60
APP	enhances	gene	0.60
ACHE	disrupts	gene	0.60
ALZHEIMER'S DISEASE	activates	disease	0.60
APOE	activates	gene	0.60
ACHE	inhibits	gene	0.60

Targeting Hypotheses (17)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa	0.887	-	Do β-amyloid plaques and neurofibrillary
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate	0.785	-	Do β-amyloid plaques and neurofibrillary
Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Choli	0.769	-	Do β-amyloid plaques and neurofibrillary
SASP-Mediated Cholinergic Synapse Disruption	0.763	neurodegeneration	Senolytic therapy for age-related neurod
Cholinergic Basal Forebrain-Hippocampal Circuit Protection	0.760	neuroscience	Circuit-level neural dynamics in neurode

Endosomal trafficking defects are the common upstream lesion	0.730	neurodegeneration	What determines the temporal sequence of
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A	0.669	neurodegeneration	What are the mechanisms by which gut mic
Glymphatic-Cholinergic Tau Clearance Cascade	0.666	neuroscience	Circuit-level neural dynamics in neurode
APOE4-microglial complement signaling causes cholinergic-enr	0.630	neurodegeneration	What determines the temporal sequence of
Selective Cholinergic Protection via APP Pathway Modulation	0.629	neurodegeneration	Clinical Trial Landscaping for Alzheimer
Locus coeruleus degeneration gates whether cholinergic dysfu	0.620	neurodegeneration	What determines the temporal sequence of
NAMPT-Centered NAD+ Restoration to Reverse Basal Forebrain C	0.616	neurodegeneration	Do β-amyloid plaques and neurofibrillary
Basal forebrain NGF/TrkA trophic failure is an upstream trig	0.610	neurodegeneration	What determines the temporal sequence of
TREM2-C1Q Competitive Binding to Prevent Complement-Mediated	0.591	neurodegeneration	Do β-amyloid plaques and neurofibrillary
Cholinergic Attention Modulation Hypothesis	0.499	methodology	Unable to extract research questions - t
Amyloid first impairs cholinergic terminals through alpha7 n	0.450	neurodegeneration	What determines the temporal sequence of
SULF-Mediated Protection of Cholinergic Tau Transport Pathwa	0.380	neuroscience	Trans-synaptic tau spreading and propaga

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (15)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Plasma ATN biomarkers across AD continuum in Chilean cohort	clinical	Alzheimer's disease	0.950	0.00	Chilean older adults (n=318) w	proposed	N/A
Electroacupuncture ST37 treatment for DSS-induced colitis in mice	validation	colitis	0.950	0.00	mice	proposed	N/A
Tau depletion effects on neuronal development in primary cultures	exploratory		0.900	0.00	primary rodent neuronal cultur	proposed	N/A
Differential GWAS of schizophrenia vs PTSD	exploratory	schizophrenia, post-traumatic	0.900	0.00	human patients - European ance	proposed	N/A
Tau depletion effects on neuronal development in primary cultures	exploratory		0.900	0.00	primary rodent neuronal cultur	proposed	N/A
Creation and validation of 3xAD-ChAT-Cre mouse model	validation	Alzheimer's disease	0.900	0.00	3xAD-ChAT-Cre transgenic mice	proposed	N/A
HFD-induced cognitive dysfunction and neuroinflammation in mice	validation	diet-induced cognitive dysfunc	0.900	0.00	adult Swiss male mice	proposed	N/A
Adoptive transfer of TCRAβ-Tregs in AD mouse model	validation	Alzheimer's disease	0.900	0.00	transgenic mice expressing chi	proposed	N/A
GTEx brain tissue expression analysis of MAPT/CRHR1 locus	exploratory	schizophrenia, post-traumatic	0.850	0.00	human brain tissue samples fro	proposed	N/A
α7nAChR agonist treatment rescues HFD-induced memory deficits	validation	diet-induced cognitive dysfunc	0.850	0.00	HFD-fed adult Swiss male mice	proposed	N/A
Microtubule domain analysis in adult axons	exploratory		0.800	0.00	adult rodent axons	proposed	N/A
Tau depletion effects on microtubule domains in adult axons	exploratory		0.800	0.00	adult rodent neurons	proposed	N/A
α7nAChR knockout mice show enhanced HFD sensitivity	validation	diet-induced cognitive dysfunc	0.800	0.00	Chrna7 knockout mice	proposed	N/A
Cholinergic System Dysfunction in DLB — Mechanisms and Therapeutic Res	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Clinical, Immunological, and Vesicular Markers in Sarcopenia and Presarcopenia. [PMID:40917056]	Shuliko LM, Svarovsky DA, Spirina LV, Og	Front Biosci (Landmark Ed)	2025	1
CD47-blocking antibody interferes with neutrophil extracellular traps formation [PMID:39951937]	Diao Y, Hao M, Xie M, Hu X, Tan R, Wang	J Neuroimmunol	2025	1
Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Indu [PMID:40116141]	Xie G, Jiang G, Huang L, Sun S, Li X, Wu	CNS Neurosci Ther	2025	1
Enhanced anticancer activity of nanoemulsified cardamom extract via modulation o [PMID:41658858]	["Soltani T", "Karimian M", "Vaziri H",	Biochemistry and biophysics re	2026	0
Astrocytic α7-nicotinic acetylcholine receptors mediate pain information process [PMID:41453579]	Teng T, Yang S, Li J, Wang H, Wu F, He Y	Neurobiology of disease	2026	0
Signal-Level Determinants of Cognitive Decline With PPIs versus H2RAs: Transport [PMID:41663888]	Saihati HAA, Ahmed BY, Mosaad RM, El-Gar	Molecular nutrition & food res	2026	0
Cataract Aggravates Alzheimer-Like Pathologies and Cognitive Deficits in an APP/ [PMID:40580389]	Geng Z, Yu ZY, Tan J, Wang XY, Zeng GH e	Neurosci Bull	2026	0
HOPS disruption impairs APP trafficking and processing, promoting exosomal secre [PMID:41525887]	Draper D, George AE, Veenendaal T, van D	Neurobiol Dis	2026	0
TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393]	Feiten AF, Dahm K, Schlepckow K, van Len	Nat Commun	2026	0
APP-C31 pathology as a target in neurodegenerative diseases. [PMID:41639863]	Yip KC, Ho WF, Liu Y, Dawe GS	J Biomed Sci	2026	0
Decoding Alzheimer's disease through down syndrome: insights from a genetically [PMID:41709686]	Russell JK, Schlachetzki Z, Rafii MS	Curr Opin Neurol	2026	0
Apps for people with vision impairment: an international review of practitioner [PMID:41734772]	Gothwal VK, Miller A, Boon MY, Subramani	Clin Exp Optom	2026	0
Impaired TGFβ Signaling in Plaque-Associated Microglia. [PMID:41750318]	Krzyzan O, Kuhla A, Spittau B, Vidovic N	Biomolecules	2026	0
APP as an innate injury-response molecule. [PMID:41864298]	Olmsted ZT, Sofroniew MV	Neurobiol Dis	2026	0
Nicotine Suppresses Human Memory Th Cell Subsets With Preferential Effects on Ce [PMID:41928597]	Gholizadeh F, Hajiaghayi M, Rahbari N, C	Eur J Immunol	2026	0
CRISPR-Cas9 and next-generation gene editing strategies for therapeutic interven [PMID:41931258]	Khan MS, Zafar I, Jamal A, Bahwerth FS,	Acta Neurol Belg	2026	0
Akkermansia muciniphila reduces neuroinflammation and Aβ deposition via tryptoph [PMID:41715194]	Wang B, Pan M, Yang L, Xu J, Ye C, Li Y,	Alzheimer's research & therapy	2026	0
Alpha 7 nicotinic acetylcholine receptor contributes to long-term cognitive reco [PMID:41270982]	Nguyen DT, Mendoza K, Hall C, Tan C, Cha	Experimental neurology	2026	0
Integrated transcriptomic, proteomic, and metabolomic analyses reveal molecular [PMID:41850064]	["Wang H", "Liu Y", "Jiang K", "Yin J",	Poultry science	2026	0
Alzheimer's disease basics: we all should know. [PMID:40639927]	Das S	Neurological research	2026	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning CHOLINERGIC in their description or question text

Endosomal trafficking defects are the common upstream lesion linking APP process

Score: 0.730 · neurodegeneration · 2026-04-25

AD-risk trafficking defects in SORL1/BIN1/PICALM/retromer may generate parallel early outputs: amyloidogenic APP sorting

Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Com

Score: 0.669 · neurodegeneration · 2026-04-02

## Mechanistic Overview Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Communication start

Glymphatic-Cholinergic Tau Clearance Cascade

Score: 0.666 · neuroscience · 2026-04-07

## Mechanistic Overview Glymphatic-Cholinergic Tau Clearance Cascade starts from the claim that modulating MAPT within t

APOE4-microglial complement signaling causes cholinergic-enriched synaptic vulne

Score: 0.630 · neurodegeneration · 2026-04-25

APOE4 may bias microglia toward complement-mediated pruning that disproportionately strips vulnerable long-range choline

Selective Cholinergic Protection via APP Pathway Modulation

Score: 0.629 · neurodegeneration · 2026-04-04

## Mechanistic Overview Selective Cholinergic Protection via APP Pathway Modulation starts from the claim that modulatin

Locus coeruleus degeneration gates whether cholinergic dysfunction or amyloid/ta

Score: 0.620 · neurodegeneration · 2026-04-25

Early noradrenergic loss may shift inflammatory tone, amyloid clearance, and cholinergic resilience, thereby modulating

NAMPT-Centered NAD+ Restoration to Reverse Basal Forebrain Cholinergic Neuron Me

Score: 0.616 · neurodegeneration · 2026-04-16

## **Molecular Mechanism and Rationale** The nicotinamide adenine dinucleotide (NAD+) biosynthetic pathway represents a

Basal forebrain NGF/TrkA trophic failure is an upstream trigger that makes choli

Score: 0.610 · neurodegeneration · 2026-04-25

Loss of retrograde NGF-TrkA support could destabilize basal-forebrain cholinergic neurons early, lowering cortical acety

TREM2-C1Q Competitive Binding to Prevent Complement-Mediated Cholinergic Synapse

Score: 0.591 · neurodegeneration · 2026-04-16

**Molecular Mechanism and Rationale** The TREM2-C1Q competitive binding hypothesis centers on the intricate molecular i

Cholinergic Attention Modulation Hypothesis

Score: 0.499 · methodology · 2026-04-12

## Mechanistic Overview Cholinergic Attention Modulation Hypothesis starts from the claim that modulating CHRNA7 within

Amyloid first impairs cholinergic terminals through alpha7 nicotinic receptor-de

Score: 0.450 · neurodegeneration · 2026-04-25

Soluble amyloid oligomers may injure cholinergic terminals via CHRNA7-linked calcium dysregulation, making cholinergic d

SULF-Mediated Protection of Cholinergic Tau Transport Pathways

Score: 0.380 · neuroscience · 2026-04-26

This hypothesis proposes that upregulating SULF1/SULF2 sulfatase activity provides dual neuroprotection by simultaneousl